Breaking News Instant updates and real-time market news.

ADS

Alliance Data

$209.46

1.405 (0.68%)

07:30
05/15/18
05/15
07:30
05/15/18
07:30

Alliance Data reports April net charge offs 6.3% vs. 6.3% last month

Reports April delinquency rate 5.3% vs. 5.3% last month.

  • 15

    May

  • 31

    May

  • 12

    Jun

ADS Alliance Data
$209.46

1.405 (0.68%)

04/17/18
SPHN
04/17/18
NO CHANGE
Target $23
SPHN
Overweight
Curo Group named a new best idea at Stephens
Stephens analyst Vincent Caintic named Curo Group (CURO) his new best idea, replacing Alliance Data (ADS), as he believes Curo's online plus branch-based distribution model can power year-over-year EPS growth of 40% in 2019. The analyst noted that he still likes Alliance Data, but he thinks the shares will be muted until credit improves in the second half of the year. Caintic has an Overweight rating and $23 price target on Curo Group.
04/17/18
RHCO
04/17/18
NO CHANGE
Target $270
RHCO
Buy
Alliance Data price target lowered to $270 from $310 at SunTrust
SunTrust analyst Andrew Jeffrey lowered his price target on Alliance Data to $270, citing expectations of more limited upside from its Epsilon and LoyaltyOne business units as well as his view of more "back-end" loaded FY18. Despite the price cut, Jeffrey contends that the company's core card services division is better positioned than the competition and justifies a "measurable relative premium", having posted a 70bp decline in charge-offs and improving delinquency figures. Jeffrey keeps his Buy rating on Alliance Data, further noting that while investors are growing less patient with inconsistent results, he still expects earnings to accelerate in the second half of this year.
04/20/18
OPCO
04/20/18
UPGRADE
OPCO
Perform
Alliance Data upgraded to Perform from Underperform at Oppenheimer
04/20/18
OPCO
04/20/18
UPGRADE
OPCO
Perform
Alliance Data upgraded to Perform on signs of stability at Oppenheimer
Oppenheimer analyst Ben Chittenden upgraded Alliance Data Systems to Perform from Underperform saying the Q1 results offered "some additional signs of stability." The analyst does not a price target for the shares.

TODAY'S FREE FLY STORIES

SRLP

Sprague Resources

$19.31

-0.24 (-1.23%)

06:05
01/23/19
01/23
06:05
01/23/19
06:05
Hot Stocks
Sprague Resources lowers FY18 adjusted EBITDA view to below $110M-$120M »

Sprague CEO David Glendon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$79.46

-1.78 (-2.19%)

06:05
01/23/19
01/23
06:05
01/23/19
06:05
Earnings
TE Connectivity reports Q1 adj. EPS $1.29, consensus $1.28 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Feb

  • 28

    May

TEVA

Teva

$18.75

-0.06 (-0.32%)

06:04
01/23/19
01/23
06:04
01/23/19
06:04
Upgrade
Teva rating change  »

Teva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

UNTY

Unity Bancorp

$19.85

0.065 (0.33%)

06:03
01/23/19
01/23
06:03
01/23/19
06:03
Earnings
Breaking Earnings news story on Unity Bancorp »

Unity Bancorp reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$25.55

-0.32 (-1.24%)

06:03
01/23/19
01/23
06:03
01/23/19
06:03
Downgrade
Continental Building rating change  »

Continental Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHX

Athersys

$1.40

-0.03 (-2.10%)

06:02
01/23/19
01/23
06:02
01/23/19
06:02
Hot Stocks
Athersys reports 'positive' results from study of MultiStem cell therapy »

Athersys announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$34.45

-0.5 (-1.43%)

05:57
01/23/19
01/23
05:57
01/23/19
05:57
Downgrade
Toll Brothers rating change  »

Toll Brothers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$17.13

-0.48 (-2.73%)

05:56
01/23/19
01/23
05:56
01/23/19
05:56
Hot Stocks
KBR secures contract for K-SAAT »

KBR announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$10.54

-0.14 (-1.31%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Hot Stocks
Infosys enters partnership with HPE GreenLake »

Infosys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

WY

Weyerhaeuser

$24.55

-0.54 (-2.15%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Initiation
Weyerhaeuser initiated  »

Weyerhaeuser initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SNE

Sony

$48.46

-1.705 (-3.40%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Hot Stocks
Sony announces formation of Sony Home Entertainment & Sound Products »

Sony Visual Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$36.43

-0.74 (-1.99%)

, LEN

Lennar

$43.48

-0.63 (-1.43%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Upgrade
D.R. Horton, Lennar rating change  »

D.R. Horton upgraded to…

DHI

D.R. Horton

$36.43

-0.74 (-1.99%)

LEN

Lennar

$43.48

-0.63 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

ZNGA

Zynga

$4.33

0.065 (1.53%)

05:53
01/23/19
01/23
05:53
01/23/19
05:53
Periodicals
Zynga founder raising up to $700M for new investment fund, Axios reports »

Zynga founder Mark Pincus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

YELP

Yelp

$35.37

-0.895 (-2.47%)

05:51
01/23/19
01/23
05:51
01/23/19
05:51
Periodicals
SCOTUS won't hear lawsuit over defamatory Yelp reviews, The Verge reports »

The Supreme Court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HII

Huntington Ingalls

$196.46

-3.82 (-1.91%)

05:50
01/23/19
01/23
05:50
01/23/19
05:50
Downgrade
Huntington Ingalls rating change  »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

KCDMY

Kimberly-Clark de Mexico

$0.00

(0.00%)

05:49
01/23/19
01/23
05:49
01/23/19
05:49
Downgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

05:47
01/23/19
01/23
05:47
01/23/19
05:47
Upgrade
Daimler AG rating change  »

Daimler AG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$161.22

-5.52 (-3.31%)

05:44
01/23/19
01/23
05:44
01/23/19
05:44
Hot Stocks
CNOOC announces 2019 business strategy, development plan »

CNOOC announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

, AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

05:43
01/23/19
01/23
05:43
01/23/19
05:43
Hot Stocks
Biohaven allowed to proceed with BHV-3241 Phase 3 clinical trial »

Biohaven Pharmaceutical…

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

ASML

ASML

$159.39

-3.34 (-2.05%)

05:38
01/23/19
01/23
05:38
01/23/19
05:38
Hot Stocks
ASML, Nikon, Carl Zeiss sign agreement to settle all litigation »

Nikon, ASML Holding, and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

05:36
01/23/19
01/23
05:36
01/23/19
05:36
Hot Stocks
Aslan says varlitinib pre-clinical data published online in Cancers »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAMR

Lamar Advertising

$73.53

-0.59 (-0.80%)

05:35
01/23/19
01/23
05:35
01/23/19
05:35
Recommendations
Lamar Advertising analyst commentary  »

Lamar Advertising price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

ABBV

AbbVie

$88.70

-0.81 (-0.90%)

05:33
01/23/19
01/23
05:33
01/23/19
05:33
Initiation
AbbVie initiated  »

AbbVie assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 28

    Jan

  • 18

    May

PFE

Pfizer

$42.26

-0.26 (-0.61%)

05:31
01/23/19
01/23
05:31
01/23/19
05:31
Downgrade
Pfizer rating change  »

Pfizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 18

    May

XOM

Exxon Mobil

$71.89

-1.09 (-1.49%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Hot Stocks
Exxon Mobil, REG enter joint research agreement with Clariant »

ExxonMobil and Renewable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 10

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.